NCT06072729

Comparison of Magnesium Sulphate Versus Cold Compress in IV Cannula Induces Phlebitis

Status unknown NA Last updated 10 October 2023

What this trial tests

NA trial testing comparison of magnesium sulphate versus cold compression in Patient With IV Cannula Induce Phlebitis in 70 participants. Status unknown.

Timeline

30 September 2023

Primary endpoint
31 March 2024

31 March 2024

Quick facts

Lead sponsor	University of Health Sciences Lahore
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	70
Start date	30 September 2023
Primary completion	31 March 2024
Estimated completion	31 March 2024

Drugs / interventions tested

• comparison of magnesium sulphate versus cold compression

Conditions studied

• Patient With IV Cannula Induce Phlebitis — all drugs for Patient With IV Cannula Induce Phlebitis →

Sponsor

University of Health Sciences Lahore

Who can join

Adults 18 to 50, any sex, with Patient With IV Cannula Induce Phlebitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The use of intravenous (IV) devices is an integral part of patient care in hospitals, clinics, maternity home etc. approximately 80% of hospitalized patients receive I.V therapies. Phlebitis is a complication that is frequently associated with intravenous therapy. Phlebitis is the inflammation of a vein. It most commonly occurs in superficial veins. It is characterized by local pain, tenderness, swelling, induration, and erythema of the venous tract, and a palpable cord-like vein on the infusion site. The most common causes of phlebitis may be mechanical, chemical, and bacterial. Phlebitis may lead to life-threatening complications such as pain, Cellulitis, gangrene and it leads to amputation of the limb. The possibility of clot formation in the veins can lead to serious complications such as deep vein pulmonary embolism, which can cause sudden death. Other complications include septic shock, thrombophlebitis requiring supportive treatment, metastatic infection, the formation of liver abscesses, and endocarditis due to septic emboli. Patients with chronic diseases like diabetes, coronary heart disease, renal failure, hepatic encephalopathy, neurological conditions, and those who are bedridden for extended periods, as well as newborns, face difficulties in maintaining intravenous (IV) cannulas. As a result, needs to maintain central lines for fluids and medication, which is another source of infection. These complications can lead to prolonged hospital stays, increased medical costs, reduced patient satisfaction, and a lower quality of life for the affected individuals. Here the question arises for nurses to check the effectiveness of magnesium sulphate versus cold compress. To find the answer to this question this study will be conducted with the objective of comparing magnesium sulfate versus cold compression on patients with a peripheral intravenous cannula (PIVC) induced phlebitis, hospital-based comparative study and the simple random sampling technique will be used to collect a sample of sixty participants and will be equally distributed into two groups. The study will be conducted in Lahore general hospital Lahore Punjab Pakistan.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.